Mibolerone (Cheque Drops)
Veterinary steroid made to suppress heat in female dogs; not studied in people and very damaging to the liver.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Mibolerone (Cheque Drops)?
Mibolerone (Cheque Drops) is an extremely potent steroid of the male-hormone type, developed as a veterinary product to suppress heat in female dogs; it has since been withdrawn from several markets. It has never been approved as a human medicine and has not been studied in people. Among bodybuilders it spread as an aggression booster before competition or heavy lifting.
It puts a heavy load on the liver, and in dogs prolonged use caused liver changes. The aggression and irritability it causes cannot be controlled, and the risk cannot be estimated. It shuts down the body's own testosterone production, and recovery can take weeks to months. In dogs, tumors of the ovary were described with prolonged use; this cannot be applied directly to humans, but it cannot be ignored either. It is so potent that an error in dilution or measuring can lead to a serious overdose. It must not be used in pregnancy, because it causes masculinization of the fetus. It is banned in competitive sport all year round.
Original purpose
A veterinary product for suppressing estrus in bitches.
Human trials
None. Never approved for human therapeutic use.
Main risks
Marked hepatotoxicity, complete HPTA suppression, tumour risk described in dogs.
Legal status
No human drug approval. WADA-banned year-round (S1).
No anecdote collected yet.
Data console
Lab data
Sokolowski JH, Geng S . Biological evaluation of mibolerone in the female Beagle.. American journal of veterinary research.
Sokolowski JH, Kasson CW . Effects of mibolerone on conception, pregnancy, parturition, and offspring in the Beagle.. American journal of veterinary research.
Seaman WJ . Canine ovarian fibroma associated with prolonged exposure to mibolerone.. Toxicologic pathology.
Williams TM, Kind AJ, Hyde WG . Characterization of urinary metabolites of testosterone, methyltestosterone, mibolerone and boldebone in greyhound dogs.. Journal of veterinary pharmacology and therapeutics.
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Severe liver injury: markedly hepatotoxic due to the 17-alpha-methyl group; prolonged dosing produced hepatic changes in dogs.
- Marked aggression and irritability: this is precisely why it is used in some circles, but the effect is uncontrollable and its risk cannot be estimated.
- Tumour risk: ovarian fibroma was described in a long-term canine study after prolonged mibolerone exposure (Seaman 1985).
- HPTA suppression: endogenous testosterone production shuts down, recovery can take weeks to months and may require post-cycle therapy.
- Lipid deterioration: falling HDL cholesterol is a class effect of androgens and implies cardiovascular risk with prolonged use.
Contraindications · 4
- Existing liver disease or elevated baseline ALT/AST: absolute contraindication.
- Dyslipidemia or existing cardiovascular disease: androgens worsen the lipid profile.
- Pregnancy and breastfeeding: androgenic action causes fetal virilization, use is prohibited.
- Competitive sport under testing: WADA bans anabolic agents year-round (S1).
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Biological evaluation of mibolerone in the female Beagle.
Sokolowski JH, Geng S
Effects of mibolerone on conception, pregnancy, parturition, and offspring in the Beagle.
Sokolowski JH, Kasson CW
Canine ovarian fibroma associated with prolonged exposure to mibolerone.
Seaman WJ
Characterization of urinary metabolites of testosterone, methyltestosterone, mibolerone and boldebone in greyhound dogs.
Williams TM, Kind AJ, Hyde WG
Telegram
Have a question about Mibolerone (Cheque Drops)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.